Childhood nephrotic syndrome

Sumboonnanonda A, Vongjirad A, Suntornpoch V, Petrarat S. Adrenal function after prednisolone treatment in childhood nephrotic syndrome. J Med Assoc Thai 1994 77(3) 126-9. 

Flamahira K, lijima K, Tanaka R, Nakamura FI, Yoshikawa N. Recovery from cyclosporine-associated arteriolopathy in childhood nephrotic syndrome. Pediatr Nephrol 2001 16 723-727. 

Yap FIK, Cheung W, Murugasu B, Sim SK, Seah CC, and Jordan SC. Thi and Th2 cytokine mRNA profiles in childhood nephrotic syndrome evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 1999 10 529-537. 

Inherited deficit Childhood Nephrotic syndrome Asthma... 

Teeninga N, Kist-van Holthe JE, Van Rijswijk N, De Mos NI, Hop WCJ, Wetzels JFM, et al. Expending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome. J Am Soc Nephrol 2013 24(l) 149-59. 

Gershen RS, Brody AS, Duffy LC, Springate JE (1994) Prognostic value of sonography in childhood nephrotic syndrome. Pediatr Nephrol 8 76-78... 

C7. Chandra, R. K., Manchanda, S. S., Srivastava, R. N., and Soothill, J. F., Differential protein clearances in Indian children with the nephrotic syndrome. Arch. Dis. Childhood 45, 491-495 (1970). 

F4. Fuchshuber, A., Gribouval, O., Ronner, V., Kroiss, S., Karle, S., Brandis, M., and Hildebrandt, F., Clinical and genetic evaluation of familial steroid-responsive nephrotic syndrome in childhood. J. Am. Soc. Nephrol. 12, 374-378 (2001). 

Kobayahi T, Suzuki J, Watansbe M, Suzuki S, Yohida K, Kume K, Suzuki H. Changes in platdd caldum concentration by thromboxane Aj stimulation in patients with nephrotic syndrome of childhood. Nephron 1997 77 309-14... 

Holt RCL, Webb NJA. Management of nephrotic syndrome in childhood. Curr Paediatr 2002 12 551-60. 

British Association for Paediatric Nephrology. Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet 1991 337 1555-1557. 

Nephrotic syndrome Hepatic synthesis Liver disease Diabetes mellitus Estrogens/pregnancy Childhood Neural tube defects Ataxia telangiectasia Down s syndrome... 

Intravascular hemolysis Ineffective erythropoiesis Estrogens/pregnancy Hepatocellular disease Nephrotic syndrome (Hp 1-1) Childhood... 

Severe in vivo hemolysis Nephrotic syndrome Childhood... 

The purine synthase inhibitor mizoribine is phosphorylated to the active form mizoribine 5 -monophosphate, which selectively inhibits inosine monophosphate dehydrogenase and guanosine monophosphate synthetase. Mizoribine has been used to treat systemic lupus erythematosus, lupus nephritis, nephrotic syndrome, and other childhood diseases. 

The nephrotic syndrome (NS) is defined by gross proteinuria, hypalbuminaemia, and oedema. Nephrotic children are prone to thrombembolic complications, infections, and intravascular volume depletion with the risk of acute renal failure. In childhood the most common variety is idiopathic NS, but it can occur in the course of many different glomerular diseases. Mem-branoproliferative GN, membranous glomerulopathy, and lupus nephritis are frequently presenting with NS. The congenital NS of the Finnish type and familial focal and segmental glomerulosclerosis are examples for inherited forms of NS (also see Chaps. 3,21,23). 

---